Tirzepatide 40mg (R&D Only)

Rated 4.50 out of 5 based on 2 customer ratings
(2 customer reviews)

Tirzepatide Pen
Tirzepatide Pen A pre-filled research device containing a 40 mg version of tirzepatide that is only used for controlled laboratory research and development. Tirzepatide Pen is supplied in a sealed condition to aid in formulation research, delivery method assessment, and compound stability analysis.

2 reviews for Tirzepatide 40mg (R&D Only)

  1. Rated 4 out of 5

    Ava O

    Superb packaging and purity. Research on advanced obesity and insulin resistance is best served by the combination of retatrutide and tirzepatide.

  2. Rated 5 out of 5

    George J

    For dose-response modeling, the 40 mg dose is ideal. Alluvi is our preferred method for GLP-1/GIP research due to its consistency.

Only logged in customers who have purchased this product may leave a review.